It is also worth noting that in some neurodegenerative diseases, RARβ signalling has been shown to have therapeutic benefits in rodent models of these diseases (Lee et al., 2014; Medina et al., 2020; Ciancia et al., 2022). This evidence concerns the gene RARB and neurodegenerative disease.